INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 20, 2016 |
Director, President & CSO
Trans History: 628
|
Director, President & CSO | Form 5 | Bona fide gift | 536 | -- | 64,594 |
| Dec 20, 2016 |
Director, President & CSO
Trans History: 628
|
Director, President & CSO | Form 5 | Bona fide gift | 536 | -- | 64,058 |
| Dec 16, 2016 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 89,427 | -- | 500,000 |
| Dec 16, 2016 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 89,427 | -- | 159,324 |
| Nov 22, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 59,788 | -- | 414,156 |
| Nov 15, 2016 |
Director
Trans History: 524
|
Director | Form 4 | Bona fide gift | 1,000 | -- | 35,500 |
| Nov 07, 2016 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Bona fide gift | 7,876 | -- | 23,950 |
| Oct 03, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 531 | -- | 151,825 |
| Jul 21, 2016 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 500,000 | -- | 500,000 |
| Jul 21, 2016 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 500,000 | -- | 67,976 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.